小娜 发表于 2020-7-16 15:28:53

MET基因相关汇总帖

深入解析MET扩增NSCLChttps://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58517

MET基因突变及扩增肺癌https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58512&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

MET抑制剂的序贯用药策略https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58518&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

MET抑制剂的选择和轮换https://mp.weixin.qq.com/s/8oqvnbBb7bVkJ1zzgjWn2g

命运大转盘：MET TKI的继发突变耐药机制https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58511&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

曲美替尼使用说明书https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58871&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

抗血管生成药治疗NSCLC https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=59099&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

EGFR突变NSCLC患者的MET扩增耐药机制https://mp.weixin.qq.com/s/tgXkB-vzsi0c_fLjV-4vtg

火凤凰的治疗史https://mp.weixin.qq.com/s/ZQsSNX7HplKzl5fHWmBOIw

MET 14外显子跳跃突变、MET原发扩增和EGFR TKI耐药后产生的MET扩增是三类NSCLC的驱动基因。MET TKI可分成二类：I型（克唑替尼、INC280、X-396、Tepotinib和沃利替尼）和II型（卡博替尼、XL880、Merestinib和MGCD265）。

I型（克唑替尼、INC280、X-396、Tepotinib和沃利替尼）

克唑替尼（塞可瑞）使用说明书https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58895&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

克唑替尼的心脏不良反应https://mp.weixin.qq.com/s/wV6J9l0HSjkl96YggNuMgQ

诺华的cMET新药INC280https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=9887&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

Capmatinib（INC280）https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58510&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

INC280使用说明https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=79763&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

INC280治疗MET ex14跳跃突变晚期NSLCC https://mp.weixin.qq.com/s/CTsNlbsatpC6IhMg_uWsxw

【ASCO2020】Capmatinib（INC280）治疗高度MET扩增晚期NSLCC https://mp.weixin.qq.com/s/TvRizsFSFdNzcCdy_9qBOA

新药：c-Met抑制剂Tepotinib https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58508&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

奥希替尼联合沃利替尼方案https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58519&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

MET基因改变导致ALK二代药耐药后，克唑替尼有效！https://mp.weixin.qq.com/s/LLPmAW-A1FtmA_rKdKCs_w

II型（卡博替尼、XL880、Merestinib和MGCD265）

Cabozantinib（XL184，卡博替尼）的服药说明https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=29051&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

XL184（卡博替尼）用药说明【整理版】https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=29206&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

卡博替尼（Cabozantinib，XL184）https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=58507&extra=page%3D1%26filter%3Dauthor%26orderby%3Ddateline

卡博替尼治疗NSCLC一期临床结果https://mp.weixin.qq.com/s/4drLComPZZfWMYdswAIW7A

小分子MET抑制剂Merestinib一期临床结果https://mp.weixin.qq.com/s/dkecyh8u2ikpSi2xGWBqbA

Lishante 发表于 2021-1-3 17:26:13

啥是1型，2型？

Victory1234 发表于 2021-4-16 12:35:16

收藏，感谢分享！

yigggg 发表于 2021-4-16 14:36:36

拉住妈妈的手999 发表于 2022-2-18 00:42:13

非常感谢！

向日葵的微笑 发表于 2022-7-6 17:03:55

收藏，感谢

nini~888 发表于 2022-7-14 22:19:07

感谢分享！

Smileemma 发表于 2022-7-26 21:35:43

感谢分享！！！！！！！

行运小超人 发表于 2022-10-29 06:56:19

页: [1]
查看完整版本: MET基因相关汇总帖